Modulation of Cancer Cell Antigens by Interferon
Author Information
Author(s): P. Giacomini, M. Mottolese, R. Fraioli, M. Benevolo, I. Venturo, P.G. Natali
Primary Institution: Regina Elena Institute, Rome, Italy
Hypothesis
A low therapeutic efficacy of IFN-a in the treatment of solid tumors might be related to its inability to elicit cellular responses.
Conclusion
The study found that a single dose of IFN-a can induce antigenic modulation in some breast and ovarian cancer cells, but the response is limited.
Supporting Evidence
- Significant modulation of at least one antigen was observed in seven out of 11 tested cases.
- Antigenic modulation was detected in cases where it was not expected.
- The study suggests that the treatment can modify tumor cells in vivo.
Takeaway
Doctors tested a treatment that uses a special medicine to change cancer cells, and they found it worked for some but not all patients.
Methodology
Patients with breast and ovarian cancer received a single intracavitary dose of IFN-a, and their neoplastic cells were analyzed for antigen expression before and after treatment.
Limitations
Only 11 out of 24 cases could be evaluated due to poor viability or contamination of neoplastic cells.
Participant Demographics
Seven patients with breast cancer and four with ovarian cancer, all free of chemotherapy for at least one month prior to treatment.
Want to read the original?
Access the complete publication on the publisher's website